PPARGC1A and metabolic dysfunction-associated steatotic liver disease: The degree of hepatic PPARGC1A methylation was reported to correlate with the measure of insulin resistance, HOMA-IR3, and plasma fasting insulin across NAFLD-affected and healthy individuals, and PPARGC1A was markedly hypermethylated in the livers of NAFLD patients (35).